Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Petrelintide (ZP8396) Petrelintide (ZP8396) is a novel SC-administered, long-acting amylin analog, developed by Zealand Pharma (Sborg, Denmark), a peptide drug discovery and development company, which is currently in early-stage clinical trials (phase 1 clinical trials: ClinicalTrials.gov Identifier NCT05511025, NCT05096598 and NCT05613387) [116]
You can request a consultation to explore whether this approach fits your needs.
BPC-157 The Gold Standard for Soft Tissue Healing Among the best peptides for joint pain, BPC-157 stands in a league of its own
Specific research areas include: Regulation of nitric oxide and endothelial signaling pathways Actin dynamics and cell migration processes Extracellular matrix deposition and remodeling Oxidative stress mitigation and redox balance Modulation of gene expression related to repair and immune signaling The combined formulation allows for the evaluation of overlapping and divergent signaling effects without the need for parallel administration protocols
US$ 25.01
US$ 27.36
US$ 27.84
US$ 25.42
US$ 25.51
US$ 26.61
US$ 29.45
US$ 25.44
US$ 25.64
US$ 29.33
